A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|15|1|37-47

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.15, Iss.1, 2015-01, pp. : 37-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Therapy as a Cancer Treatment Paradigm

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 73-78

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy for osteosarcoma

By Quan Gerald  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 707-713

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors

By Raymond Eric   Hobday Timothy   Castellano Daniel   Reidy-Lagunes Diane   García-Carbonero Rocío   Carrato Alfredo  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 19-26

Springer Publishing Company

Access to resources Recommend Favorite